Exploring the Role of DiGAs in Enhancing Medication Adherence
An STSM experience Portugal - Germany
In recent years, Digital Health Applications have emerged as a significant innovation in healthcare, particularly in enhancing patient adherence to medication. These applications, which include digital therapeutics approved for prescription by healthcare professionals (DiGAs), represent a new frontier in personalized medicine. During a Short-Term Scientific Mission (STSM) within the ENABLE network, I had the opportunity to explore the impact of DiGAs on patient adherence and healthcare outcomes in a practical, clinical setting.
The Context: DiGAs in the German Healthcare System
Germany has been at the forefront of integrating these tools into its healthcare system. This pioneering effort allows healthcare providers to prescribe approved digital applications, either replacing or alongside traditional treatments. The goal is to support patients in managing chronic conditions, enhancing adherence to prescribed therapies, and ultimately improving health outcomes.
Central to the implementation of DiGAs in Germany is the official DiGA directory, managed by the Federal Institute for Drugs and Medical Devices (BfArM). The BfArM is an independent federal authority responsible for ensuring the safety and efficacy of medicinal products and medical devices, including digital health applications. The DiGA directory lists all approved digital health applications that have undergone rigorous evaluation by the BfArM to ensure they meet the required standards of safety, data protection, and clinical efficacy.
Since the enactment of the Digital Care Act (DVG) in December 2019, DiGAs have become an integral part of the German healthcare landscape. They can be prescribed by doctors and reimbursed by statutory health insurance providers, provided they demonstrate a “positive care effect,” which the BfArM carefully evaluates before including any application in the directory.
Key Observations and Insights
- Limited Awareness and Adoption: Despite the significant potential of digital health applications (DiGAs), awareness of these tools remains limited among both healthcare professionals and patients. The utilization of DiGAs in clinical practice is still relatively low, suggesting that while the necessary infrastructure for their prescription is available, their adoption has not yet become widespread.
- Digital Literacy Challenges: A significant barrier to the effective use of DiGAs is the varying levels of digital literacy among patients. In some cases, a lack of familiarity with digital tools can prevent patients from fully benefiting from these applications. This issue is particularly pronounced among older populations and those with limited access to technology, making digital literacy an important factor for healthcare providers to consider when recommending DiGAs.
- Specialty-Specific Applications: Currently, many DiGAs are developed for specific medical specialties and conditions, which may limit their broader application across various healthcare fields. This specialization, while beneficial for targeted interventions, highlights the need for expanding the scope of DiGA development to ensure broader applicability and impact.
- Economic Considerations: The economic impact of DiGAs is a critical consideration, particularly in terms of their long-term sustainability within healthcare systems. While clinical efficacy is the primary criterion for their inclusion in official directories, there is a pressing need for comprehensive economic evaluations to assess whether the costs associated with DiGAs are justified when compared to traditional treatment methods.
Future Directions and Collaborative Efforts
These findings highlight the need for further research and collaboration to optimize the use of prescription digital therapies in healthcare. Important next steps rely on performing an economic evaluation of these technologies to assess the long-term viability and effectiveness. Additionally, increasing awareness and education about DiGAs among healthcare providers and patients will be crucial in expanding their adoption.
The STSM provided valuable insights into the current state of DiGAs in Germany’s healthcare system. While these digital tools hold great promise for enhancing medication adherence, their full potential has yet to be realized. By addressing the challenges of digital literacy, expanding the scope of available applications, and conducting thorough economic evaluations, we can pave the way for more effective and widespread use of DiGAs in clinical practice across Europe and beyond.